Apollo
logo
  1. Home
  2. salt
  3. Pertuzumab

Pertuzumab

About Pertuzumab

Pertuzumab is a targeted prescription medicine used to treat specific types of breast cancer, particularly those that are HER2-positive. It is designed to slow down or stop the growth of cancer cells by targeting specific proteins on their surface. This treatment is always used together with other anti-cancer medicines rather than on its own. Depending on your stage of breast cancer, it is commonly given with trastuzumab and chemotherapy such as docetaxel, or with trastuzumab and other chemotherapy medicines chosen by your oncologist to provide the best possible results.

This medicine is injected as an intravenous infusion by a healthcare professional, typically in a hospital or clinic setting. It is given on a consistent, scheduled cycle to maintain its effectiveness in your body. Adopting a nutritious diet, drinking plenty of fluids, and managing stress can help support your overall well-being during this treatment.

While this treatment is highly targeted, some patients may experience common side effects such as diarrhoea, fatigue, or temporary hair loss. It is crucial to monitor how you feel and contact your healthcare provider immediately if you experience serious symptoms like shortness of breath, swelling in your legs, or signs of an infection.

Do not take this if you have had a severe allergic reaction to this medicine or any of its ingredients in the past. Before starting, talk to your doctor if you have a history of heart conditions, liver damage, or if you have previously received radiation therapy to your chest area.

This medicine can interact with other treatments that affect your heart, so it is vital to share a complete list of your medications with your doctor. If you are pregnant, planning to become pregnant, or breastfeeding, you should not use this medicine due to the risk of severe harm to the baby. Older adults should also discuss their specific health risks with their doctor before starting.

Uses of Pertuzumab

Pertuzumab is used in the treatment of Breast Cancer. The detailed uses of Pertuzumab are as follows: • Metastatic HER2-Positive Breast Cancer: Pertuzumab is used in combination with trastuzumab and docetaxel as a first-line treatment for patients who haven’t received prior anti-HER2 therapy for metastatic disease. • Neoadjuvant Therapy: Pertuzumab is given before surgery to shrink tumors in locally advanced or early-stage HER2-positive breast cancer. • Adjuvant Therapy: Pertuzumab is used after surgery in patients with early-stage HER2-positive breast cancer who are at high risk of recurrence.

Medicinal Benefits

When used as directed as part of your treatment plan, this medicine may provide the following benefits:

  • Targeted Cancer Cell Destruction: Unlike traditional chemotherapy, which affects all rapidly dividing cells, this medicine specifically targets HER2-positive cancer cells. This helps spare healthy cells from unnecessary damage.
  • Enhanced Treatment Effectiveness: When used in combination with other anti-HER2 therapies, it provides a dual-blockade effect. This stops cancer cells from growing more effectively than using a single therapy alone.
  • Improved Long-Term Outcomes: Clinical studies show that adding this medicine to standard treatment plans helps keep patients cancer-free for longer and improves overall survival rates in advanced cases.

Directions for Use

  • Follow your doctor’s instructions on the dosage and timing of this medication.
  • Pertuzumab will be administered by a nurse or doctor.
  • Do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Pertuzumab

Common Side Effects (Usually mild):

  • Diarrhoea or loose stools
  • Feeling unusually tired or weak (fatigue)
  • Hair thinning or hair loss
  • Nausea or vomiting
  • Rashes or dry, itchy skin
  • Numbness or tingling in the hands or feet
     

Serious Side Effects (Consult your doctor right away):

  • Signs of heart problems, including shortness of breath, a persistent cough, swelling in the legs, ankles, or feet, or an irregular heartbeat
  • Signs of an allergic or infusion reaction, such as fever, chills, dizziness, hives, or swelling of the face and throat
  • Severe or watery diarrhoea that does not stop, which can lead to severe dehydration
  • Signs of infection, including a high fever, chills, sore throat, or body aches
  • Contact your doctor or seek emergency medical care immediately if you develop severe shortness of breath, chest pain, swelling of the face or throat, a high fever, signs of infection, persistent severe diarrhoea, or swelling in your legs or ankles.

Drug Warnings

  • Verify Your Medicine Before Infusion: Always verify with your nurse that the vial has been checked and matches your prescription before the infusion begins.
  • Check the Infusion Solution: Make sure the liquid solution is clear to slightly pearly and colourless to pale brown; do not receive it if it contains visible particles or is discoloured.
  • Keep Heart Monitoring Appointments: Keep all scheduled appointments for heart monitoring (like echocardiograms or MUGA scans), as this medicine can affect your heart muscle function.
  • Avoid Pregnancy During Treatment: Do not get pregnant while using this medicine and for at least 7 months after your final dose, as it can cause serious birth defects or fetal death.
  • Avoid Live Vaccines: Avoid receiving live vaccines during your treatment period to prevent serious viral complications.
  • Report Infusion Reaction Immediately: If you experience any sudden chills, fever, or breathing difficulties during the injection process, notify the nursing staff immediately.

Drug Interactions

  • Heart Medication Interaction Warning: Taking this medicine alongside other cancer therapies that can harm the heart (such as anthracycline-based chemotherapies) may increase the risk of heart damage. Always inform your doctor of all prescription drugs, over-the-counter medicines, and supplements you are taking.

Drug-Drug Interactions Checker List:

  • ANASTROZOLE
  • CARMUSTINE
  • DAUNORUBICIN
  • ABCIXIMAB
  • BLEOMYCIN
  • BUPIVACAINE
  • Safety Advice

    • Safety Warning

      Alcohol

      unsafe

      Alcohol intake might increase the risk of worsening your condition. Hence, avoid alcohol consumption till your condition improves.

    • Safety Warning

      Pregnancy

      unsafe

      Pertuzumab is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Pertuzumab. Use reliable methods of birth control while on treatment with Pertuzumab.

    • Safety Warning

      Breast Feeding

      caution

      It is not known whether Pertuzumab is excreted in breast milk. Hence, if you are breastfeeding, inform your doctor before receiving Pertuzumab. Your doctor will weigh the benefits and the risks before prescribing this medicine.

    • Safety Warning

      Driving

      caution

      Pertuzumab will be administered in the hospital setting. Driving is not recommended while on therapy.

    • Safety Warning

      Liver

      caution

      No clinical trials have assessed the impact of hepatic impairment on the pharmacokinetics of Pertuzumab. Hence, if you have a pre-existing or a history of liver disease, inform your doctor.

    • Safety Warning

      Kidney

      caution

      Limited data are available on the effect of Pertuzumab in kidney-impaired patients. Hence, if you have a pre-existing or a history of kidney disease, inform your doctor.

    • Safety Warning

      Children

      unsafe

      Pertuzumab is not recommended for use in children as the safety and efficacy are not established.

    Habit Forming

    No

    Diet & Lifestyle Advise

    • Eat Small Meals: Eat small, frequent meals throughout the day to help manage nausea and maintain your strength.
    • Stay Hydrated: Stay thoroughly hydrated by drinking water, broths, or electrolyte solutions, especially if you experience diarrhoea.
    • Prevent Infections: Wash hands frequently and avoid crowds or contact with sick individuals, as this treatment can lower your white blood cell count and make you more prone to infections.
    • Stay Active: Incorporate gentle physical activities like stretching or short walks into your daily routine to help combat treatment-related fatigue, but always consult your doctor first.
    • Sun Protection: Protect your skin from the sun by wearing protective clothing and applying a broad-spectrum sunscreen, as your skin may become more sensitive during treatment.

    Special Advise

    • Avoid intercourse while on treatment with Pertuzumab.
    • Regular, complete blood count monitoring is advised.  Also, monitoring of liver function is important while receiving Pertuzumab.
    • Pertuzumab should not be administered for more than six cycles for patients with early-stage breast cancer.
    • All patients should be tested for HER2 test before starting the treatment regimen.

    Patients Concern

    Disease/Condition Glossary

    Breast Cancer: Breast cancer is a type of cancer with abnormal growth in the cells of the breast. There are different kinds of breast cancer, such as cancer occurring in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), and in the fatty tissue or the fibrous connective tissue within the breast. Symptoms of breast cancer include a lump in the breast, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, a lump or swelling under the arm, unexplained change in shape, size or appearance of the breast, peeling, flaking or scaling of the skin. 

    FAQs

    Pertuzumab is used to treat Breast Cancer.

    Pertuzumab contains Pertuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth and, finally, initiation of apoptosis.

    Inform your doctor whether you have received any other breast cancer treatment containing doxorubicin in your medication list. Pertuzumab may cause left ventricular dysfunction, anaphylaxis, hypersensitivity reactions, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Pertuzumab.

    It is injected as an intravenous (IV) infusion into a vein by a trained healthcare professional in a clinic or hospital setting. Talk to your doctor if you have questions about the infusion process.

    No, you should not receive this medicine if you are pregnant, as it can cause severe harm or death to an unborn baby. Talk to your doctor about effective birth control options.

    Yes, hair thinning or hair loss is a common side effect when this medicine is used in combination with other chemotherapy drugs. Talk to your doctor or pharmacist about what to expect.

    The infusion is typically given once every three weeks, but your exact schedule will depend on your specific treatment plan. Talk to your doctor to confirm your schedule.

    In some countries, including India, biosimilar versions of Pertuzumab may be available. Biosimilars are highly similar to the original medicine and are approved only after meeting strict quality, safety, and effectiveness standards. Always receive the exact product prescribed by your oncologist, and do not switch between brands unless your healthcare provider recommends it.

    There is no direct interaction, but alcohol can worsen side effects like fatigue, nausea, and dehydration. Talk to your doctor or pharmacist for personalised advice.

    Contact your healthcare team immediately if you experience severe or persistent diarrhoea, as they can recommend safe anti-diarrheal medications and help you stay hydrated. Talk to your doctor before taking any over-the-counter remedies.

    This medicine can occasionally weaken the heart muscle, leading to a decreased ability to pump blood. Your doctor will perform regular heart scans to monitor your heart function during treatment. Talk to your doctor if you experience shortness of breath or swelling.

    You should avoid live vaccines during your treatment, as your immune system may be weakened. Talk to your doctor before receiving any vaccinations.

    Author Details

    Doctor image
    We provide you with authentic, trustworthy and relevant information.
    Apollo 247 Floating Button
    PERTUZUMAB | View uses, side-effects, medicines | Apollo Pharmacy